Cargando…

Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies

Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Statland, Jeffrey M., Odrzywolski, Karen J., Shah, Bharati, Henderson, Don, Fricke, Alex F., van der Maarel, Silvére M., Tapscott, Stephen J., Tawil, Rabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560242/
https://www.ncbi.nlm.nih.gov/pubmed/26345300
http://dx.doi.org/10.3233/JND-150077
_version_ 1782388892834463744
author Statland, Jeffrey M.
Odrzywolski, Karen J.
Shah, Bharati
Henderson, Don
Fricke, Alex F.
van der Maarel, Silvére M.
Tapscott, Stephen J.
Tawil, Rabi
author_facet Statland, Jeffrey M.
Odrzywolski, Karen J.
Shah, Bharati
Henderson, Don
Fricke, Alex F.
van der Maarel, Silvére M.
Tapscott, Stephen J.
Tawil, Rabi
author_sort Statland, Jeffrey M.
collection PubMed
description Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle biopsies and compare to possible pathological mechanisms of disease. Methods: We performed a cross-sectional study on quadriceps muscle biopsies from 32 genetically confirmed FSHD participants, compared to healthy volunteers and myotonic dystrophy type 1 as disease controls. Biopsies were divided into groups to evaluate apoptosis rates, capillary density, myonuclear and satellite cell counts. Results: Apoptosis rates were increased in FSHD (n = 10, 0.74% ) compared to myotonic dystrophy type 1 (n = 10, 0.14% , P = 0.003) and healthy volunteers (n = 14, 0.13% , P = 0.002). Apoptosis was higher in FSHD patients with the smallest residual D4Z4 fragments. Capillary density was decreased in FSHD1 (n = 10, 316 capillaries/mm(2)) compared to healthy volunteers (n = 15, 448 capillaries/mm(2), P = 0.001). No differences were seen in myonuclear or satellite cell counts. Conclusions: Preliminary evidence for increased apoptosis rates and reduced capillary density may reflect histopathological correlates of disease activity in FSHD. The molecular-pathological correlates to these changes warrants further investigation.
format Online
Article
Text
id pubmed-4560242
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-45602422015-09-04 Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies Statland, Jeffrey M. Odrzywolski, Karen J. Shah, Bharati Henderson, Don Fricke, Alex F. van der Maarel, Silvére M. Tapscott, Stephen J. Tawil, Rabi J Neuromuscul Dis Research Report Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle biopsies and compare to possible pathological mechanisms of disease. Methods: We performed a cross-sectional study on quadriceps muscle biopsies from 32 genetically confirmed FSHD participants, compared to healthy volunteers and myotonic dystrophy type 1 as disease controls. Biopsies were divided into groups to evaluate apoptosis rates, capillary density, myonuclear and satellite cell counts. Results: Apoptosis rates were increased in FSHD (n = 10, 0.74% ) compared to myotonic dystrophy type 1 (n = 10, 0.14% , P = 0.003) and healthy volunteers (n = 14, 0.13% , P = 0.002). Apoptosis was higher in FSHD patients with the smallest residual D4Z4 fragments. Capillary density was decreased in FSHD1 (n = 10, 316 capillaries/mm(2)) compared to healthy volunteers (n = 15, 448 capillaries/mm(2), P = 0.001). No differences were seen in myonuclear or satellite cell counts. Conclusions: Preliminary evidence for increased apoptosis rates and reduced capillary density may reflect histopathological correlates of disease activity in FSHD. The molecular-pathological correlates to these changes warrants further investigation. IOS Press 2015-09-02 /pmc/articles/PMC4560242/ /pubmed/26345300 http://dx.doi.org/10.3233/JND-150077 Text en IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License.
spellingShingle Research Report
Statland, Jeffrey M.
Odrzywolski, Karen J.
Shah, Bharati
Henderson, Don
Fricke, Alex F.
van der Maarel, Silvére M.
Tapscott, Stephen J.
Tawil, Rabi
Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title_full Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title_fullStr Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title_full_unstemmed Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title_short Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
title_sort immunohistochemical characterization of facioscapulohumeralmuscular dystrophy muscle biopsies
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560242/
https://www.ncbi.nlm.nih.gov/pubmed/26345300
http://dx.doi.org/10.3233/JND-150077
work_keys_str_mv AT statlandjeffreym immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT odrzywolskikarenj immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT shahbharati immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT hendersondon immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT frickealexf immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT vandermaarelsilverem immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT tapscottstephenj immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies
AT tawilrabi immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies